Vnitr Lek 2018, 64(10):903-910 | DOI: 10.36290/vnl.2018.125

Is functional dyspepsia really that frequent?

Vít Navrátil, Pavol Dvoran, Vladimír Ďurana, Jiří Ehrmann*, Vlastimil Procházka
II. interní klinika - gastroenterologická a geriatrická LF UP a FN Olomouc

The literature shows, that the prevalence of functional dyspepsia is between 11 and 29.2 % in general population. The first goal of this study was to present a narrative review of the current findings of functional dyspepsia. The second goal was to find out the prevalence of functional dyspepsia in the II. Internal Clinic of Gastroenterology and Geriatry in Teaching Hospital of Olomouc (Czech Republic). According to the clinical experience, the prevalence of patients with functional dyspepsia seems to be not as high as literature shows. Normal gastroscopy findings are mandatory for the diagnosis of functional dyspepsia. That is why we examined 302 patients with indications for gastroscopy. According to the Rome IV criteria and normal gastroscopy findings, the diagnosis of functional dyspepsia was made only in 10 (3.31 %) patients. 108 patients have received repeated gastroscopy after 4 to 6 months period. But, none of them came with the diagnosis functional dyspepsia. Our results suggest, that the prevalence of functional dyspepsia after careful gastroscopic examination is lower than in the previous literature. This observation could change our view of functional dyspepsia and its diagnostics.

Keywords: functional dyspepsia; gastroscopy; prevalence; Rome IV criteria

Received: December 6, 2017; Accepted: March 26, 2018; Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátil V, Dvoran P, Ďurana V, Ehrmann J, Procházka V. Is functional dyspepsia really that frequent? Vnitr Lek. 2018;64(10):903-910. doi: 10.36290/vnl.2018.125.
Download citation

References

  1. Ehrmann J. Funkční dyspepsie. Med praxi 2013; 10(2): 50-53.
  2. Rejchrt S et al. Prevalence a sociodemografická charakteristika dyspepsie v České republice. Nucleus: Hradec Králové 2005. ISBN 80-86225-77-1.
  3. Ehrmann J. Funkční dyspepsie. Klin Farmakol Farm 2009; 23(1): 35-41.
  4. Rejchrt S, Koupil I, Kopáčová M et al. Prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic. Eur J Gastroenterol Hepatol 2008; 20(9): 898-905. Dostupné z DOI: <http://dx.doi.org/10.1097/MEG.0b013e3282fa7508>. Go to original source... Go to PubMed...
  5. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: A global perspective. World J Gastroenterol 2006; 12(17): 2661-2666. Go to original source... Go to PubMed...
  6. Ferreira-Maia AP, Matijasevich A, Wang YP. Epidemiology of functional gastrointestinal disorders in infants and toddlers: a systematic review. World J Gastroenterol 2016; 22(28): 6547-6558. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v22.i28.6547>. Go to original source... Go to PubMed...
  7. Bureš J, Kopáčová M, Koupil I et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006; 11(1): 56-65. Dostupné z DOI: <http://dx.doi.org/10.1111/j.0083-8703.2006.00369.x>. Go to original source... Go to PubMed...
  8. Bureš J, Kopáčová M, Koupil I et al. Significant decrease in prevalence of Helicobacter pylori in the Czech Republic. World J Gastroenterol 2012; 18(32): 4412-4418. Dostupné z DOI: <http://dx.doi.org/10.3748/wjg.v18.i32.4412>. Go to original source...
  9. Mařatka Z. Functional gastrointestinal disorders-50 years' experience in comparison with the Rome criteria. Folia Gastroenterol Hepatol 2005; 3(1): 10-16.
  10. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV. Gastroenterol 2016; 150(6): 1262-1279. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2016.02.032>. Go to original source... Go to PubMed...
  11. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterol 2006; 130(5): 1377-1390. Go to original source... Go to PubMed...
  12. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 2012; 367(17): 1626-1635. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMra1207068>. Go to original source... Go to PubMed...
  13. Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterol 1994; 107(1): 271-293. Go to original source... Go to PubMed...
  14. Piche T. Tight junctions and IBS-the link between epithelial permeability, low-grade inflammation, and symptom generation? Neurogastroenterol Motil 2014; 26(3): 296-302. Dostupné z DOI: <http://dx.doi.org/10.1111/nmo.12315>. Go to original source... Go to PubMed...
  15. Mayer EA, Savidge T, Shulman RJ. Brain-gut microbiome interactions and functional bowel disorders. Gastroenterol 2014; 146(6): 1500-1512. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2014.02.037>. Go to original source... Go to PubMed...
  16. Rajilic-Stojanovic M, Jonkers DM, Salonen A et al. Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol 2015; 110(2): 278-287. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2014.427>. Go to original source... Go to PubMed...
  17. Simren M, Barbara G, Flint H et al. Intestinal microbiota in functional bowel disorders: a Rome Foundation working team report. Gut 2013; 62(1): 159-176. Dostupné z DOI: <http://dx.doi.org/10.1136/gutjnl-2012-302167>. Go to original source... Go to PubMed...
  18. Jones MP, Dilley JB, Drossman DA et al. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships. Neurogastroenterol Motil 2006; 18(2): 91-103. Dostupné z DOI: <http://dx.doi.org/10.1111/j.1365-2982.2005.00730.x>. Go to original source... Go to PubMed...
  19. Kellow JE, Delvaux M, Azpiroz F et al. Principles of applied neurogastroenterology: physiology/motility-sensation. Gut 1999; 45(Suppl 2): II17-II24. Go to original source... Go to PubMed...
  20. Pasricha PJ. Neurogastroenterology: a great career choice for aspiring gastroenterologists thinking about the future. Gastroenterol 2011; 140(4): 1126-1128. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2011.02.025>. Go to original source... Go to PubMed...
  21. Drossman DA. Functional GI disorders: what's in a name? Gastroenterol 2005; 128(7): 1771-1772. Go to original source... Go to PubMed...
  22. Torsoli A, Corazzieri E. The WTR's, the delphic oracle and the Roman conclaves. Gastroenterol Int 1991; 4: 44-45.
  23. Milholland AV, Wheeler SG, Heieck JJ. Medical assessment by a delphi group opinion technic. N Engl J Med 1973; 288(24): 1272-1275. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJM197306142882405>. Go to original source... Go to PubMed...
  24. Stanghellini V, Chan FK, Hasler WL et al. Gastroduodenal disorders. Gastroenterol 2016; 150(6): 1380-1392. Dostupné z DOI: <http://dx.doi.org/10.1053/j.gastro.2016.02.011>. Go to original source... Go to PubMed...
  25. Drossman DA. Functional gastrointestinal disorders: what's new for Rome IV? Lancet Gastroenterol Hepatol 2016; 1(1): 6-8. Dostupné z DOI: <http://dx.doi.org/10.1016/S2468-1253(16)30022-X>. Go to original source... Go to PubMed...
  26. Drossman DA, Chang L, Bellamy M et al. Severity in irritable bowel syndrome: a Rome working team report. Am J Gastroenterol 2011; 106(10): 1749-1759. quiz 1760. Dostupné z DOI: <http://dx.doi.org/10.1038/ajg.2011.201>. Go to original source... Go to PubMed...
  27. Schmulson MJ, Drossman DA. What is new in Rome IV. Neurogastroenterol Motil 2017; 23(2): 151-163. Dostupné z DOI: <http://dx.doi.org/10.5056/jnm16214>. Go to original source... Go to PubMed...
  28. Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in japan and in the World. J Neurogastroenterol Motil 2015; 21(3): 320-329. Dostupné z DOI: <http://dx.doi.org/10.5056/jnm14165>. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.